Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement.
Details
Serval ID
serval:BIB_E4ECB589C87A
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement.
Journal
Journal of Magnetic Resonance Imaging
ISSN
1053-1807[print], 1053-1807[linking]
Publication state
Published
Issued date
2004
Volume
20
Number
2
Pages
288-293
Language
english
Notes
Publication types: Clinical Trial ; Clinical Trial, Phase I ; Comparative Study ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
PURPOSE: To evaluate gadocoletic acid (B-22956), a gadolinium-based paramagnetic blood pool agent, for contrast-enhanced coronary magnetic resonance angiography (MRA) in a Phase I clinical trial, and to compare the findings with those obtained using a standard noncontrast T2 preparation sequence. MATERIALS AND METHODS: The left coronary system was imaged in 12 healthy volunteers before B-22956 application and 5 (N = 11) and 45 (N = 7) minutes after application of 0.075 mmol/kg of body weight (BW) of B-22956. Additionally, imaging of the right coronary system was performed 23 minutes after B-22956 application (N = 6). A three-dimensional gradient echo sequence with T2 preparation (precontrast) or inversion recovery (IR) pulse (postcontrast) with real-time navigator correction was used. Assessment of the left and right coronary systems was performed qualitatively (a 4-point visual score for image quality) and quantitatively in terms of signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), vessel sharpness, visible vessel length, maximal luminal diameter, and the number of visible side branches. RESULTS: Significant (P < 0.01) increases in SNR (+42%) and CNR (+86%) were noted five minutes after B-22956 application, compared to precontrast T2 preparation values. A significant increase in CNR (+40%, P < 0.05) was also noted 45 minutes postcontrast. Vessels (left anterior descending artery (LAD), left coronary circumflex (LCx), and right coronary artery (RCA)) were also significantly (P < 0.05) sharper on postcontrast images. Significant increases in vessel length were noted for the LAD (P < 0.05) and LCx and RCA (both P < 0.01), while significantly more side branches were noted for the LAD and RCA (both P < 0.05) when compared to precontrast T2 preparation values. CONCLUSION: The use of the intravascular contrast agent B-22956 substantially improves both objective and subjective parameters of image quality on high-resolution three-dimensional coronary MRA. The increase in SNR, CNR, and vessel sharpness minimizes current limitations of coronary artery visualization with high-resolution coronary MRA.
Keywords
Adult, Contrast Media, Coronary Vessels/anatomy & histology, Gadolinium/diagnostic use, Humans, Image Processing, Computer-Assisted, Imaging, Three-Dimensional, Inhalation/physiology, Magnetic Resonance Angiography/methods, Male, Organometallic Compounds/diagnostic use
Pubmed
Web of science
Create date
02/03/2010 16:04
Last modification date
20/08/2019 16:08